novel
respiratori
pathogen
later
name
middl
east
respiratori
syndrom
coronaviru
merscov
first
report
septemb
ministri
health
kingdom
saudi
arabia
ksa
sinc
emerg
novel
pathogen
singapor
enhanc
nation
surveil
system
detect
potenti
import
viru
singapor
suspect
adult
merscov
case
travel
histori
mersaffect
countri
refer
tan
tock
seng
hospit
ttsh
screen
clinic
manag
ttsh
tertiarycar
hospit
also
includ
communic
diseas
centr
cdc
design
nation
referr
centr
emerg
infecti
diseas
singapor
island
cityst
locat
southern
tip
malay
peninsula
southeast
asia
land
area
km
popul
size
septemb
sixteen
percent
singapor
popul
muslim
major
malay
ethnic
annual
local
pilgrim
perform
hajj
umrah
annual
islam
pilgrimag
mecca
ksa
travel
return
pilgrimag
increas
risk
introduc
viru
singapor
moreov
singapor
major
travel
hub
tourist
visit
year
round
addit
across
strait
north
singapor
first
laboratoryconfirm
case
merscov
infect
report
april
peninsular
malaysia
patient
man
develop
pneumonia
respiratori
distress
return
pilgrimag
saudi
arabia
januari
decemb
singapor
receiv
total
visitor
malaysia
averag
take
consider
risk
import
merscov
singapor
trivial
describ
retrospect
review
surveil
data
includ
demograph
clinic
inform
suspect
merscov
case
manag
ttsh
emerg
depart
ed
septemb
decemb
surveil
data
review
includ
demograph
clinic
inform
pertain
suspect
case
use
guidelin
singapor
ministri
health
moh
suspect
case
defin
person
clinic
sign
symptom
suggest
pneumonia
sever
respiratori
infect
breathless
epidemiolog
link
countri
merscov
case
report
within
preced
day
suspect
case
admit
isol
ward
laboratori
test
confirm
clinic
manag
definit
suspect
case
similar
epidemiolog
criteria
probabl
case
report
world
health
organ
laboratori
diagnosi
detect
merscov
hospit
laboratori
compris
two
realtim
revers
transcriptasepolymeras
chain
reaction
rrtpcr
assay
sensit
screen
assay
target
region
upstream
e
protein
gene
upe
follow
specif
assay
target
open
read
frame
gene
test
report
detect
sampl
ct
valu
confirm
made
perform
repeat
test
sampl
rna
nation
public
health
laboratori
singapor
number
suspect
case
also
underw
test
influenza
laboratori
test
influenza
viru
includ
subtyp
perform
realtim
assay
aitbiotech
abtestm
aitbiotech
singapor
use
respiratori
sampl
onestep
multiplex
rrtpcr
kit
design
detect
influenza
influenza
b
subtyp
sampl
posit
matrix
gene
neg
subtyp
test
use
singleplex
pcr
season
andor
depend
travel
histori
surveil
period
total
patient
visit
ttsh
ed
merscov
assess
tabl
median
age
case
rang
year
age
year
maletofemal
ratio
suspect
case
seen
ed
singapor
resid
major
malay
ethnic
rest
compris
chines
indian
minor
ethnic
nonresid
compris
visitor
europ
middl
east
asian
countri
compar
resid
younger
median
age
vs
year
p
tend
male
nonresid
vs
resid
p
case
seen
ed
admit
singapor
resid
admit
patient
fulfil
clinic
epidemiolog
criteria
suspect
case
two
hundr
fortyeight
hospit
patient
combin
nasal
throat
sampl
test
merscov
result
test
neg
remain
case
test
merscov
mild
upper
respiratori
ill
fulfil
criteria
suspect
case
diagnosi
clinic
rule
manag
medic
team
time
report
singapor
detect
case
merscov
infect
almost
year
enhanc
surveil
overal
discharg
diagnos
hospit
patient
upper
respiratori
tract
infect
pneumonia
diagnos
acut
pyelonephr
acut
tonsil
acut
pharyng
etc
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
chest
infect
sepsi
dengu
fever
hospit
patient
n
patient
test
influenza
viru
test
posit
influenza
b
compar
resid
nonresid
like
posit
influenza
result
vs
p
none
patient
posit
influenza
result
vaccin
year
prior
hospit
admiss
overal
median
length
stay
lo
rang
day
case
discharg
day
differ
lo
influenza
median
rang
day
noninfluenza
case
median
rang
day
p
group
hospit
patient
n
clinic
andor
radiolog
evid
pneumonia
median
age
patient
pneumonia
rang
year
significantli
older
without
evid
pneumonia
median
age
rang
year
p
maletofemal
ratio
pneumonia
twenti
patient
also
test
posit
influenza
eight
eight
four
b
median
lo
patient
pneumonia
influenza
pcrposit
rang
day
lo
day
three
patient
pneumonia
need
icu
care
two
also
posit
influenza
pcr
test
one
one
differ
lo
influenza
median
rang
day
noninfluenza
case
median
rang
day
p
patient
pneumonia
streptococcu
pneumonia
legionella
urinari
antigen
test
perform
patient
diagnos
pneumonia
pneumonia
urinari
antigen
detect
six
patient
pneumonia
posit
blood
urin
cultur
one
patient
influenza
viru
use
pcr
test
pneumonia
urinari
antigen
codetect
two
patient
legionella
urinari
antigen
detect
patient
median
age
six
patient
pneumococc
diseas
rang
year
four
patient
chronic
medic
condit
diabet
copd
surveil
programm
data
demonstr
sever
key
find
public
health
import
first
half
admiss
fulfil
full
moh
criteria
suspect
merscov
case
suggest
surveil
system
highli
sensit
clinician
tend
err
side
caution
determin
patient
requir
hospit
admiss
second
infecti
diseas
clinician
ensur
suspect
case
assess
thoroughli
rule
merscov
infect
mani
test
influenza
possibl
aetiolog
agent
eg
pneumonia
third
high
proport
suspect
case
fact
develop
vaccineprevent
infect
influenza
pneumococc
diseas
ill
episod
result
hospit
might
avoid
vaccin
prior
travel
find
demonstr
potenti
benefit
commun
pretravel
vaccin
influenza
pneumococc
diseas
burden
diseas
prevent
vaccin
insignific
although
singapor
moh
recommend
influenza
vaccin
key
strategi
reduc
influenzaassoci
hospit
death
recent
populationbas
studi
show
adult
age
year
report
receiv
find
merscov
surveil
programm
influenza
immun
preced
month
moreov
hajj
pilgrim
advis
vaccin
influenza
pneumococc
diseas
administr
vaccin
highli
variabl
mandatori
meningococc
vaccin
routin
administ
pilgrim
structur
programm
vaccin
popul
although
vaccin
wide
avail
polyclin
privat
gener
practition
clinic
travel
clinic
privat
restructur
hospit
healthcar
provid
educ
import
influenza
pneumococc
vaccin
hajj
pilgrim
order
advoc
provid
meningococc
vaccin
pilgrim
studi
sever
limit
data
collect
patient
mainli
surveil
purpos
clinic
inform
readili
access
furthermor
may
underestim
rate
influenza
vaccin
data
collect
studi
includ
vaccin
given
singapor
resid
healthcar
institut
vaccin
histori
may
welldocu
nonresid
conclus
studi
reflect
experi
institut
carri
enhanc
surveil
merscov
continu
vigil
must
maintain
given
everpres
threat
diseas
global
especi
region
addit
still
need
promot
campaign
highlight
import
influenza
vaccin
person
protect
enhanc
nation
immun
programm
includ
influenza
vaccin
facilit
access
vaccin
servic
especi
highrisk
group
oversea
travel
elderli
reduct
influenzaassoci
hospit
death
vital
need
maintain
vigil
emerg
infecti
diseas
merscov
infect
